Petrakis, I., Springer, S. A., Davis, C., Ralevski, E., Gu, L., Lew, R., Hermos, J., Nuite, M., Gordon, A. J., Kosten, T. R., Nunes, E. V., Rosenheck, R., Saxon, A. J., Swift, R., Goldberg, A., Ringer, R., & Ferguson, R. (2022). Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans. Addiction Science & Clinical Practice, 17(1). https://doi.org/10.1186/s13722-022-00286-6
Columbia Affiliation:
Subjects:
Opioid Epidemic in the United States
(OpenAlex Topic)
Global Epidemiology of HIV and Drug Use
(OpenAlex Topic)
Epidemiology and Interventions for Substance Use Disorders
(OpenAlex Topic)
Buprenorphine
(MeSH)
COVID-19
(MeSH)
Opioid-Related Disorders
(MeSH)
Veterans
(MeSH)
Publication Type:
Article
Unique ID:
10.1186/s13722-022-00286-6
PMID:
Publication Date:
Data Source:
Scopus